1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,018 | 0,026 | 29.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | Bioretec Oy: Bioretec Ltd's Half-year report 2026: H1 close signals momentum | 206 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 13 August 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's half-year report for January-June 2026. The complete half-year report is attached to this... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 05.08. | Bioretec Oy: Panu Mikkonen appointed as Chief Financial Officer of Bioretec | 219 | GlobeNewswire (Europe) | Bioretec Ltd | Company announcement | 5 August 2026 at 4:00 p.m. EESTBioretec Ltd, a pioneer in absorbable orthopedic implants, appoints Panu Mikkonen (M.Sc. Econ) as Chief Financial Officer, effective... ► Artikel lesen | |
| 02.07. | Bioretec Oy: Inside information: Chief Financial Officer Tuukka Paavola will leave the company | 461 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 2 July 2026 at 14.30 EESTBioretec Ltd and Tuukka Paavola have mutually agreed that Paavola will not continue in his position. Paavola will leave his role with immediate... ► Artikel lesen | |
| 17.06. | Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team | 2 | Cision News | ||
| 17.06. | Bioretec concludes change negotiations | 2 | Cision News | ||
| 04.06. | Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher | 1 | Cision News | ||
| 02.06. | Bioretec Ltd - Manager's transactions - Jordy Winters | 294 | PR Newswire | TAMPERE, Finland, June 2, 2026 /PRNewswire/ -- Bioretec Oy Company release 2 June 2026 at 13:25 p.m. EEST
Bioretec Oy - Managers' TransactionsPerson subject to the notification requirementName:... ► Artikel lesen | |
| 01.06. | Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency | 449 | PR Newswire | Bioretec Ltd - Inside information - 1 June 2026 at 19:00 EESTTAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd initiates change negotiations in accordance with the Finnish Act on... ► Artikel lesen | |
| 01.06. | The Board of Directors of Bioretec Ltd resolved on a new stock option plan | 414 | PR Newswire | TAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd Company Announcement -1 June 2026 at 19:05 p.m. EEST
The Board of Directors of Bioretec Ltd has resolved to establish a new... ► Artikel lesen | |
| 15.05. | Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 585 | PR Newswire | TAMPERE, Finland, May 15, 2026 /PRNewswire/ -- Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen | |
| 15.05. | Bioretec Oy: Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 406 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March 2026. The complete business review is attached to this... ► Artikel lesen | |
| 13.05. | Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 475 | PR Newswire | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EESTHELSINKI, May 13, 2026 /PRNewswire/ -- To be aligned with industry reporting standards, Bioretec will transition to reporting an... ► Artikel lesen | |
| 13.05. | Bioretec Oy: Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 284 | GlobeNewswire (Europe) | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EEST
Bioretec clarifies its 2026-2028 financial target regarding the sales marginTo be aligned with industry reporting standards, Bioretec will... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors | 488 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 20:40 p.m. EEST
Bioretec Ltd's resolutions of the constitutive meeting of the Board of DirectorsAt its... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the Annual General Meeting | 529 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting Bioretec Ltd's Annual General... ► Artikel lesen | |
| 08.05. | Bioretec Oy: Bioretec Ltd's resolutions of the Annual General Meeting | 263 | GlobeNewswire (Europe) | Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting
Bioretec Ltd's Annual General Meeting was held on Friday 8 May 2026 as a hybrid... ► Artikel lesen | |
| 29.04. | Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö) | 376 | PR Newswire | HELSINKI, April 29, 2026 /PRNewswire/ -- Bioretec Ltd Company release 29 April 2026 at 16:40 p.m. EEST
Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities... ► Artikel lesen | |
| 28.04. | Bioretec Ltd - Manager's transactions - Stephen Industries Inc Oy | 392 | PR Newswire | HELSINKI, April 28, 2026 /PRNewswire/ -- Bioretec Oy Company release 28 April 2026 at 16:55 p.m. EEST
Bioretec Oy - Managers' Transactions____________________________________________Person... ► Artikel lesen | |
| 28.04. | Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Kustaa Poutiainen) | 437 | PR Newswire | HELSINKI, April 28, 2026 /PRNewswire/ -- Bioretec Ltd Company release 28 April 2026 at 15:55 p.m. EEST
Bioretec Ltd ("Bioretec" or the "Company") has received on 28 April 2026 the following... ► Artikel lesen | |
| 28.04. | New shares of Bioretec Ltd registered with the trade register | 296 | PR Newswire | Bioretec Ltd Company announcement 28 April 2026 at 13:10 EESTNOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG... ► Artikel lesen |
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,240 | +0,61 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 23 Euro auf "Buy" belassen. Die operative Grundleistung des Herstellers radioaktiver... ► Artikel lesen | |
| INTUITIVE SURGICAL | 321,40 | -0,11 % | Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage | ||
| DRAEGERWERK | 110,60 | -0,36 % | Drägerwerk unter Druck: PFAS-Debatte wird brisant | ||
| INSULET | 125,55 | +0,20 % | President and CEO Of Insulet Purchased $162K In Stock | ||
| CYTOSORBENTS | 0,288 | -0,69 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| GENEDX | 86,32 | -0,02 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| REVENIO GROUP | 14,780 | -1,20 % | Revenio Group Corporation: Revenio's iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening | Revenio Group Corporation | Press Release | August 17, 2026 at 09:00:00 EEST
Revenio's iCare DRSplus fundus imaging system is included in an FDA-cleared AI-based solution in the United States in which... ► Artikel lesen | |
| OPTOMED | 1,636 | -0,97 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| FRESENIUS | 45,855 | -0,75 % | EQS-News: Schutzgemeinschaft der Kapitalanleger e.V.: Fresenius, Gerresheimer, TUI und viele weitere Unternehmen präsentieren sich im Rahmen der SdK-Anlegerforen | Emittent / Herausgeber: Schutzgemeinschaft der Kapitalanleger e.V.
/ Schlagwort(e): Konferenz/Konferenz
Fresenius, Gerresheimer, TUI und viele weitere Unternehmen präsentieren... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,920 | -0,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,13 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,520 | +0,66 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 47,780 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,790 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,310 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen BIORETEC OY kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,89 % bei einem Aktienkurs von 0,021 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.